NO741142L - Analogifremgangsmåte ved fremstilling av et terapeutisk aktivt benzopyranderivat. - Google Patents

Analogifremgangsmåte ved fremstilling av et terapeutisk aktivt benzopyranderivat.

Info

Publication number
NO741142L
NO741142L NO741142A NO741142A NO741142L NO 741142 L NO741142 L NO 741142L NO 741142 A NO741142 A NO 741142A NO 741142 A NO741142 A NO 741142A NO 741142 L NO741142 L NO 741142L
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous process
benzopyran derivative
active benzopyran
Prior art date
Application number
NO741142A
Other languages
English (en)
Other versions
NO141341B (no
NO141341C (no
Inventor
Martin Winn
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO741142L publication Critical patent/NO741142L/no
Publication of NO141341B publication Critical patent/NO141341B/no
Publication of NO141341C publication Critical patent/NO141341C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO741142A 1973-04-05 1974-03-29 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat NO141341C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34837173A 1973-04-05 1973-04-05
US05/442,033 US4049653A (en) 1973-04-05 1974-02-13 Heterocyclic esters of alkylphenyl benzopyrans

Publications (3)

Publication Number Publication Date
NO741142L true NO741142L (no) 1974-10-08
NO141341B NO141341B (no) 1979-11-12
NO141341C NO141341C (no) 1980-02-20

Family

ID=26995674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO741142A NO141341C (no) 1973-04-05 1974-03-29 Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt benzopyranderivat

Country Status (13)

Country Link
US (1) US4049653A (no)
JP (1) JPS5035169A (no)
AU (1) AU476698B2 (no)
CA (1) CA1038383A (no)
CH (1) CH592086A5 (no)
DE (1) DE2416491C3 (no)
FI (1) FI60007C (no)
FR (1) FR2224157B1 (no)
GB (1) GB1459943A (no)
NL (1) NL7404147A (no)
NO (1) NO141341C (no)
PH (1) PH13583A (no)
SE (1) SE413191B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615397A1 (de) * 1976-04-08 1977-10-27 Sharps Ass Neue benzopyranester
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
US5498419A (en) * 1994-06-03 1996-03-12 Pars; Harry G. Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric
DE19706903A1 (de) 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
US6187203B1 (en) * 1998-12-01 2001-02-13 Academia Sinica Sample purification apparatus and method
CN101677931B (zh) * 2007-03-16 2013-01-02 株式会社资生堂 皱纹防止、改善剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880885A (en) * 1971-11-23 1975-04-29 Sandoz Ag Tertiary aminoethyl isochromans and isocoumarins
US3984419A (en) 1972-06-21 1976-10-05 E. R. Squibb & Sons, Inc. Perhydrofluorenetetrol and perhydro-phenanthrenetetrol derivatives

Also Published As

Publication number Publication date
CA1038383A (en) 1978-09-12
CH592086A5 (no) 1977-10-14
DE2416491A1 (de) 1974-10-24
NO141341B (no) 1979-11-12
FR2224157A1 (no) 1974-10-31
NL7404147A (no) 1974-10-08
PH13583A (en) 1980-07-16
SE413191B (sv) 1980-04-28
FI60007C (fi) 1981-11-10
NO141341C (no) 1980-02-20
JPS5035169A (no) 1975-04-03
US4049653A (en) 1977-09-20
DE2416491B2 (de) 1979-06-28
GB1459943A (en) 1976-12-31
FI60007B (fi) 1981-07-31
AU6664974A (en) 1975-09-18
DE2416491C3 (de) 1981-01-15
AU476698B2 (en) 1976-09-30
FR2224157B1 (no) 1977-05-06

Similar Documents

Publication Publication Date Title
NO741815L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive etylenderivater.
NO741227L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive penicillinderivater.
NO740137L (no) Analogifremgangsmåte ved fremstilling av terapeutisk virksomme karboksylsyrederivater.
NO740945L (no) Fremgangsmåte til fremstilling av et overflateaktivt stoff.
NO152751C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat.
NO740543L (no) Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater.
NO741140L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktiv 3-(4-p-fluorfenyl-1-metylbutyl)-1-hydroksy-6,6,9-trimetyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran.
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO740405L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater.
NO740675L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme dotriacontapeptidamider.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO741142L (no) Analogifremgangsmåte ved fremstilling av et terapeutisk aktivt benzopyranderivat.
NO740327L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner.
NO740349L (no) Analogifremgangsmåte ved fremstilling av antibakterielt virksomme piperazinderivater.
NO740546L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme tripeptider.
NO741744L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin.
NO741486L (no) Fremgangsmåte for fremstilling av xylitol.
FI52349C (fi) Menetelmä uusien terapeuttisesti käytettävien 2beta,16beta-piperidino- 5alfa-androstaanien valmistamiseksi.
NO741364L (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser.
NO740184L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 2-(fenoksyalkyltio)imidazolforbindelser.
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
NO741350L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive benzylaminer.
NO740411L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on.
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
FI51098C (fi) Menetelmä terapeuttisesti arvokkaan 2-okso-1-pyrrolidinyyliasetamidin valmistamiseksi.